Navigation Links
Newborns exposed to maternal smoking more irritable, difficult to soothe
Date:12/1/2008

PROVIDENCE, RI Previous studies have shown that babies exposed to tobacco in utero are more likely to have a low birth weight and are at increased risk for sudden infant death syndrome. Now new research by The Miriam Hospital reveals that these babies are also less likely to self-soothe and are more aroused and excitable than newborns whose mothers did not smoke during pregnancy.

Researchers from The Miriam Hospital's Centers for Behavioral and Preventive Medicine say early identification and targeted intervention efforts aimed at both infants and parents may help prevent possible disruption in early maternal-infant bonding and, ultimately, long-term adverse outcomes. The study is published online by the Journal of Pediatrics.

"A baby who is harder to soothe and more irritable could be more difficult to take care of and could potentially affect the developing mother-child relationship, especially for mothers who are already stressed and have fewer resources," says lead author Laura Stroud, PhD, a psychologist with The Miriam Hospital's Centers for Behavioral and Preventive Medicine. "We need better treatment programs to help women not smoke during pregnancy, to keep them from starting smoking after the baby is born, and to help them take care of an excitable or colicky baby."

Between 11 and 30 percent of women continue to smoke during pregnancy, according to the Centers for Disease Control and Prevention. In addition to the physical side effects, tobacco exposure in utero has also been linked to long-term adverse neurobehavioral outcomes in children, including conduct disorder and hyperactivity. However, researchers say relatively less attention has focused on the effects of maternal smoking on newborn neurobehavior.

In the study, Stroud and colleagues from Women & Infants Hospital in Providence, RI, and the Warren Alpert Medical School of Brown University focused on newborns between 10 and 27 days old. The researchers decided on this infant age range because it is well past the half-life of nicotine, meaning the acute effects of nicotine withdrawal were unlikely to be a factor in the study. All 56 babies 28 smoking-exposed and 28 unexposed were healthy and full-term. Maternal social class, age and alcohol use were similar in each group.

Mothers in the study were assigned to the smoking or non-smoking group based on self-reports of cigarette use during pregnancy assessed shortly after babies were born. This was verified biochemically by measuring cotinine, the primary metabolite of nicotine, in the mother's saliva. Cotinine is readily passed from mother to infant, with the baby absorbing nearly as much as the mother does.

On average, the number of cigarettes mothers smoked each day decreased over the course of the pregnancy, from about 15 cigarettes per day in the first trimester to approximately five cigarettes in the third trimester.

Postnatal smoke exposure was quantified by infant saliva cotinine levels. All infants were then assessed using the Neonatal Intensive Care Unit (NICU) Network Neurobehavioral Scale, a tool developed for the National Institutes of Health to measure the effects of prenatal drug exposure in infants, including withdrawal and general signs of stress.

According to the study's findings, smoking-exposed infants showed a greater need for handling, or external intervention, in order to be soothed and calmed down. These babies also tended to be more easily aroused and excitable.

"Although the effects of maternal smoking at 10 to 27 days were subtle, in combination with a high-stress postnatal environment and deficits in parenting, they could represent early precursors for long-term, negative behavioral outcomes," says Stroud, who is also an assistant professor of psychiatry (research) at Alpert Medical School.


'/>"/>

Contact: Jessica Collins Grimes
jgrimes2@lifespan.org
401-793-7484
Lifespan
Source:Eurekalert

Related medicine news :

1. All Newborns Should Have Ears Screened, Task Force Says
2. Five States Step Up Efforts to Screen Newborns for Cystic Fibrosis
3. Do Underweight Newborns Make for Shy Adults?
4. Seizures in newborns can be detected with small, portable brain activity monitors
5. Newborns in Intensive Care Often Exposed to Pain
6. Limit sucrose as painkiller for newborns
7. Genetic testing in newborns and children: Ethical issues affecting families and physicians
8. New research shows overheating newborns can increase the risk of SIDS
9. Alabama Begins Mandatory Screening of Newborns for Cystic Fibrosis
10. Group B Strep Down Among Newborns, Up Among Adults
11. Incubators Affect Newborns Heart Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of dynamic transitions ... the next without having to set a single keyframe in Final Cut Pro ... video production. , TransDark features dynamic transitions that momentarily splits the RGB layers of ...
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... ... 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the ... ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength ... , Removal of the homeopathic element , Adding their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to May ... Medicine will host industry leaders for the annual spring Convention & Expo, called ... industry adapt to the issues currently affecting urgent care and on-demand healthcare. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: